Oncological Outcomes of Robot-assisted PSMA-guided Salvage Surgery in Recurrent Prostate Cancer: Insights from the Prospective TRACE-I Trial
European Urology Focus · 2026-08
DOI: 10.1016/j.euf.2026.07.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Urology Focus, 2026-08. Verfasst von Lotte G Zuur und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address: l.zuur@nki.nl. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Prostate-specific membrane antigen (PSMA)-radioguided surgery (RGS) is an emerging technique providing real-time intraoperative guidance. The prospective TRACE-I trial demonstrated that robot-assisted 99mtechnetium-PSMA-Investigation & Surgery-RGS ([99mTc]Tc-PSMA-I&S-RGS) using a DROP-IN gamma probe is feasible and safe in recurrent prostate cancer (PCa). OBJECTIVE: To report the oncological outcmes of a post hoc analysis of the prospective TRACE-I trial cohort. DESIGN, SETTING, AND PARTICIPANTS: TRACE-I prospectively enrolled 30 patients with biochemical recurrence (prostate-specific antigen (PSA) ≥0.2 ng/ml after radical prostatectomy (RP) or ≥2 ng/ml above nadir after radiotherapy (RT) and ≤3 pelvic recurrences (nodal and/or local) on PSMA-positron emission tomography/computed tomography (PET/CT; 2020-2023). INTERVENTION: Patients underwent single-photon emission CT/CT and then robot-assisted PSMA-RGS. OUTCOMES MEASUREMENTS AND STATISTICAL ANALYSIS: Oncological outcomes were biochemical progression (PSA ≥0.2 ng/ml after RP or ≥2 ng/ml above nadir after RT), radiological recurrence on PSMA-PET/CT, and time to salvage therapy. Biochemical progression-free survival (bPFS), distant metastasis-free survival (dMFS), and therapy-free survival (TFS) were analysed using Kaplan-Meier and univariable Cox regression. RESULTS AND LIMITATIONS: Among 30 patients (19 RP, 9 RT, and 2 RP + RT), the median age was 68 yr, and the median PSA at RGS was 1.02 ng/ml (interquartile range, 0.46-2.86), 28 (93%) showed PSA decline after RGS, and 20 (66%) reached PSA
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address: l.zuur@nki.nl.
- Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
- Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Nuclear Medicine, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
- Department of Nuclear Medicine, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospit…
- Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
Zitieren
APA
Zuur, L. G., de Barros, H. A., Ottens, V. A., Berrens, A. C., van Oosterom, M. N., Donswijk, M. L., Hendrikx, J. J. M. A., van Leeuwen, F. W. B., van der Poel, H. G., & van Leeuwen, P. J. (2026). Oncological Outcomes of Robot-assisted PSMA-guided Salvage Surgery in Recurrent Prostate Cancer: Insights from the Prospective TRACE-I Trial. European Urology Focus. https://doi.org/10.1016/j.euf.2026.07.005
Vancouver
Zuur LG, de Barros HA, Ottens VA, Berrens AC, van Oosterom MN, Donswijk ML, et al. Oncological Outcomes of Robot-assisted PSMA-guided Salvage Surgery in Recurrent Prostate Cancer: Insights from the Prospective TRACE-I Trial. European Urology Focus. 2026. doi:10.1016/j.euf.2026.07.005
BibTeX
@article{Zuur2026,
author = {Zuur, Lotte G and de Barros, Hilda A and Ottens, Vera A and Berrens, Anne-Claire and van Oosterom, Matthias N and Donswijk, Maarten L and Hendrikx, Jeroen J M A and van Leeuwen, Fijs W B and van der Poel, Henk G and van Leeuwen, Pim J},
title = {Oncological Outcomes of Robot-assisted PSMA-guided Salvage Surgery in Recurrent Prostate Cancer: Insights from the Prospective TRACE-I Trial},
journal = {European Urology Focus},
year = {2026},
doi = {10.1016/j.euf.2026.07.005}
}
EUVIMED